Supplementary Figure S2 from Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial | Synapse
August 1, 2024Open Access
Supplementary Figure S2 from Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S2. Cohort flow diagram for patients enrolled in cohorts A and C and those included in the analyses.